Real-world evidence firms for IFX biosimilar

A string of real-world studies presented at this year’s ECCO congress point to the efficacy of infliximab biosimilar Inflectra in a range of IBD settings.

The ten studies from eight countries involve data from nearly 600 Crohn’s and ulcerative colitis patients who were switched from the reference drug Remicade to Inflectra.

The

Latest

Trending